Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liugan Shuangjie Heji for Influenza
NCT02572583Phase 2Unknown
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Nov 2014
- Primary completion
- Nov 2016
- Modality
- TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised trial of Liugan Shuangjie Heji in influenza (3 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoints: Time from medicine intake to 0.5°C drop of body temperature at 5 days and Time for the body temperature to return to normal at 5 days. Status: unknown.
02
Drugs
Liugan Shuangjie Heji
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02572583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02572583.